Inventor · disambiguated record
Stephane Birkle
Also filed as: BIRKLE STEPHANE · BIRKLE STÉPHANE
5 granted patents·4 pending applications·38 citations·filing 2007–2023
76Inventor score
Top patents by PatentIndex Score
9 records- 0188US9334330B2Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancersUNIV NANTES·Filed 2014·Granted May 10, 2016·17 cites·8 claims
- 0284US8951524B2Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for treatment of certain cancersBIRKLE STÉPHANE·Filed 2007·Granted Feb 10, 2015·17 cites·11 claims
- 0371US10745489B2Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancerOGD2 PHARMA·Filed 2018·Granted Aug 18, 2020·1 cites·12 claims
- 0469US11697689B2Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugsOGD2 PHARMA·Filed 2017·Granted Jul 11, 2023·1 cites·18 claims
- 0567US10000575B2Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancerOGD2 PHARMA·Filed 2014·Granted Jun 19, 2018·2 cites·11 claims
- 0663US2023416398A1Use of antibody against o-acetylated gd2 ganglioside to improve the therapeutic potential of drugsOGD2 PHARMA·Filed 2023·Application pending·0 cites
- 0757US2024190993A1New method to improve the anti-tumoral activity of macrophagesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0857US2024228659A1New method to improve nk cells cytotoxicityINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0933US2014044721A1Anti-gb3 antibodies useful in treating disorders associated with angiogenesisPARIS FRANCOIS·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →